UGP1 has a strong inhibitory effect on these kinds of tumor cells such as Hela and HCT116, of which the inhibitory effect of UGP1 on the human colon cancer HCT116 cell linen is relatively high (56.843 + 2.405%), which indicates that UGP1 may be a potential drug for the treatment of colon cancer. This evidence concerns the gene UGP2 and colonic neoplasm.